-
The views expressed herein do not constitute research, investment advice or trade recommendations, and do not necessarily represent the views of all AB portfolio-management teams and are subject to change over time.
The Iceland website is not available. You will be redirected to the Luxembourg website which contains funds approved for marketing in Luxembourg, and where several of these funds are not registered for marketing in Iceland.
Heimasíða Íslands er ekki aðgengileg. Þér verður vísað á heimasíðu Lúxemborgar sem inniheldur sjóði sem samþykktir eru til markaðssetningar í Lúxemborg og þar sem nokkrir þessara sjóða eru ekki skráðir til markaðssetningar á Íslandi.
Past performance does not guarantee future results. Current analyses do not guarantee future results.
Left display represents global companies with market cap over $15 billion that fall into the top half of cash flow return on investment and also in the top half of five-year median asset growth. Right display is the Russell 1000 Growth universe subdivided into quintiles of valuation measured by price-to-sales. The valuations shown are the median for each quintile.
As of December 31, 2021
Source: Credit Suisse HOLT, FactSet , FTSE Russell and AllianceBernstein(AB)
The views expressed herein do not constitute research, investment advice or trade recommendations, and do not necessarily represent the views of all AB portfolio-management teams and are subject to change over time.
Vinay Thapar is a Senior Vice President and Co-Chief Investment Officer for US Growth Equities and a Portfolio Manager for the Global Healthcare Strategy. He is also a Senior Research Analyst, responsible for covering global healthcare. Before joining the firm in 2011, Thapar spent three years at American Century Investments as a senior investment analyst responsible for healthcare. Prior to that, he worked for eight years at Bear Stearns in the Biotech Equity Research Group, most recently as an associate director. Thapar holds a BA in biology from New York University and is a CFA charterholder. Location: New York
John H. Fogarty is a Senior Vice President and Co-Chief Investment Officer for US Growth Equities. He rejoined the firm in 2006 as a fundamental research analyst covering consumer-discretionary stocks in the US, having previously spent nearly three years as a hedge fund manager at Dialectic Capital Management and Vardon Partners. Fogarty began his career at AB in 1988, performing quantitative research, and joined the US Large Cap Growth team as a generalist and quantitative analyst in 1995. He became a portfolio manager in 1997. Fogarty holds a BA in history from Columbia University and is a CFA charterholder. Location: New York
Investors in US fixed-income markets may want to strike while the iron is hot.
Gershon Distenfeld, Fahd Malik, Monika Carlson | 25 November 2024Investors need a better grasp of risk-management tools to gauge a portfolio’s strategic resilience in a rapidly changing world.
Nelson Yu, Jonathan Berkow | 21 June 2024This may be the right time for multi-asset investors to consider emerging-market assets.
02 February 2024This is a marketing communication. This information is provided by AllianceBernstein (Luxembourg) S.à r.l. Société à responsabilité limitée, R.C.S. Luxembourg B 34 305, 2-4, rue Eugène Ruppert, L-2453 Luxembourg. Authorised in Luxembourg and regulated by the Commission de Surveillance du Secteur Financier (CSSF). It is provided for informational purposes only and does not constitute investment advice or an invitation to purchase any security or other investment. The views and opinions expressed are based on our internal forecasts and should not be relied upon as an indication of future market performance. The value of investments in any of the Funds can go down as well as up and investors may not get back the full amount invested. Past performance does not guarantee future results.
This information is directed at Professional Clients only and is not intended for public use.